Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).
Open Access
- 1 September 1992
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 90 (3) , 973-980
- https://doi.org/10.1172/jci115974
Abstract
Previous studies in Caucasians with progressive systemic sclerosis (PSS) have suggested associations of antitopoisomerase I (antitopo I) autoantibodies with either serologically defined HLA-DR2 or DR5. To better define class II HLA associations with the antitopo I response, 161 PSS patients (132 Caucasians and 29 American blacks) were studied for antitopo I autoantibodies by immunodiffusion and immunoblotting, and their HLA-DRB1, DRB3, DQA1, and DQB1 alleles were determined by restriction fragment length polymorphic analysis and DNA oligotyping. Among Caucasians with antitopo I, HLA-DR5(DRB1*1101-*1104), DRB3*0202 and DQw3 (DQw7,8,9) were significantly increased in frequency. In American blacks, however, only HLA-DQB1*0301(DQw7) was significantly increased. The presence of HLA-DQB1*0301(DQw7) and other HLA-DQB1 alleles bearing the uncharged polar amino acid residue tyrosine at position 30 of the outermost domain was found in all antitopo I-positive Caucasian PSS patients compared with 66% of antitopo I-negative PSS patients (pc = 0.007) and 70% of normal controls (pc = 0.008), as well as all antitopo I-positive black patients. The association with HLA-DQB1 was independent of HLA-DR5(DRB1*1101-*1104) or any other HLA-DRB1, DRB3, or DQA1 alleles. Alternative or additional candidate epitopes for this autoimmune response include alanine at position 38 and threonine at position 77 of these same DQB1 alleles. These data suggest that genetic predisposition to the antitopo I response in PSS is associated most closely with the HLA-DQB1 locus.Keywords
This publication has 43 references indexed in Scilit:
- DNA typing for class II HLA antigens with allele-specific or group-specific amplification. IV. Typing for alleles of the HLA-DR2 groupHuman Immunology, 1991
- Nomenclature for factors of the HLA system, 1989Human Immunology, 1990
- DNA typing for class II hla antigens with allele-specific or group-specific amplification. II. typing for alleles of the DRw52-associated groupHuman Immunology, 1990
- DNA typing for class II HLA antigens with allele-specific or group-specific amplification. I. Typing for subsets of HLA-DR4Human Immunology, 1990
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988
- HLA-DR-DQ haplotypes defined by restriction fragment analysisHuman Immunology, 1987
- Lack of association of HLA‐DR antigens with progressive systemic sclerosis (scleroderma)Tissue Antigens, 1982
- HLA-D Antigens in Progressive Systemic Sclerosis (Scleroderma)Immunological Communications, 1981
- Skin manifestations of pentazocine abusePublished by Elsevier ,1980
- PREVALENCE OF DISEASE AMONG VINYL CHLORIDE AND POLYVINYL CHLORIDE WORKERSAnnals of the New York Academy of Sciences, 1975